The Risk-Appetite Test for Longevity Concentration in Pension Deals

Why a Risk Appetite Statement Needs a Number, Not Just a Sentiment

Many risk appetite statements say something reasonable-sounding about accepting longevity risk within prudent limits, without ever specifying what that limit actually is in measurable terms. For a risk like longevity concentration across pension transactions, that vagueness is exactly the gap that allows the exposure to build undetected.

A board doing real oversight of this risk needs to apply a specific test: does an explicit, numeric limit exist, and is current exposure actually being measured against it.

For directors, this test takes minutes to apply and immediately separates a functioning risk appetite framework from a decorative one.

This governance question exists because unmanaged concentration eventually produces the kind of correlated earnings shock covered in the earnings-volatility effect of longevity concentration, and the same board-level test applies just as directly to medical trend outpacing treaty economics, a related risk many life and health reinsurance boards also carry.

What Risk-Appetite Test Should a Board Apply to Longevity Concentration?

Whether an explicit numeric limit exists on correlated longevity exposure by cohort or counterparty, and whether current aggregate exposure is measured against that limit on a recurring basis.

This is a two-part test, and both parts matter. A numeric limit that exists on paper but is never actually checked against current exposure provides no real protection.

Current exposure measurement without a defined limit to compare it against provides information but no clear signal of when action is required. Only the combination, a specific limit plus a recurring measurement against it, constitutes functioning oversight of this risk.

Why Is a General Risk Appetite Statement Not Sufficient on Its Own?

A general statement about acceptable longevity risk does not translate into an actionable limit unless it is expressed as a specific, measurable threshold that management's aggregation process can be checked against.

A statement like "the organization will maintain a prudent level of longevity risk concentration" sounds like governance but functions as very little in practice. It gives management no specific target to measure against and gives the board no specific number to ask about.

The same problem shows up in why an early-warning system needs a defined escalation threshold rather than just an aggregation process without a trigger point.

What Should the Board Ask Management to Demonstrate?

A current view of aggregate longevity exposure by cohort and counterparty, measured against the board's stated risk appetite limit, refreshed on the same cadence as other capital adequacy reporting.

This is a specific, answerable request that a board can put directly to management, and the answer should be a number compared against a number, not a qualitative assurance. If management cannot produce this view on request, that inability is itself the governance finding, regardless of what the actual concentration level turns out to be once the view is built. A Capital Requirement Estimation AI Agent can help translate a concentration breach into the capital terms a board is already used to reviewing.

How Does Market Growth Change the Urgency of This Oversight?

With pension risk transfer assets surpassing $340 billion and buy-in volume up sharply in 2025, the pace at which concentration can build has increased, making periodic rather than continuous oversight riskier than it used to be.

LIMRA's data showing total PRT assets at $342.1 billion, up 13% year over year, with buy-in sales up 372% in 2025 alone, describes a market moving fast enough that a concentration position reviewed only annually could look materially different by the time of the next review. This pace argues for oversight built into standing, frequent reporting cycles rather than periodic deep dives scheduled further apart than the market itself is moving.

What Is the Governance Failure Mode Specific to This Risk?

Approving individual transactions through normal underwriting channels without ever reviewing the aggregate concentration those approvals have produced is the specific governance failure that allows this risk to go unchecked.

This failure mode is easy to miss because nothing about it looks like a governance breakdown from the inside. Every individual transaction goes through appropriate underwriting review and approval.

The gap is entirely in what never happens afterward, namely stepping back to ask what the combined effect of all those individually approved transactions has been on the organization's aggregate risk position.

Should Longevity Concentration Limits Be Part of the Formal Risk Appetite Statement?

Yes, an explicit, numeric limit on correlated longevity exposure belongs in the formal risk appetite statement rather than being left as an informal understanding among underwriting staff.

Formalizing the limit in the risk appetite statement accomplishes two things an informal understanding cannot. It creates an explicit, board-approved boundary that management is accountable to, and it creates a standing obligation to measure and report against that boundary, rather than relying on individual underwriters' judgment about when a concentration level feels uncomfortable.

What Happens If the Board Discovers the Limit Has Already Been Breached?

The board should require an explicit management plan addressing new business restrictions, retrocession options, or a deliberate, documented decision to accept the breach temporarily with a defined remediation timeline.

Discovering a breach is not itself a crisis if it triggers a clear, documented response. What would be a genuine governance failure is discovering a breach and allowing it to continue without an explicit plan and timeline, since that effectively converts a defined risk appetite limit into a suggestion rather than a boundary the organization actually operates within.

What Does a Well-Written Risk Appetite Limit Look Like?

A weak risk appetite statement reads: "the organization will maintain a prudent level of longevity concentration risk."

A functioning one reads: "no single demographic cohort or reinsurer counterparty shall represent more than 15% of total longevity reinsurance exposure, measured quarterly, with any breach escalated to the board within 30 days." The second version gives management an unambiguous target, gives the board a specific number to check quarterly, and gives auditors and rating agencies a testable governance standard rather than a sentiment to take on faith.

Boards reviewing their own risk appetite statement for this exposure should ask whether it reads more like the first example or the second, since that distinction alone predicts whether the limit will ever actually get enforced.

Oversight of longevity concentration is not complicated in concept. It requires a specific number the board has agreed to, a recurring measurement against that number, and a clear expectation of what happens if the measurement shows a breach.

What makes it easy to get wrong is that the risk builds invisibly through a sequence of individually reasonable transaction approvals, which means the board has to ask for the aggregate view proactively rather than waiting for it to be flagged.

How Does This Compare to Concentration Risks the Board Already Manages?

Most boards already set explicit numeric limits on credit concentration to a single counterparty or investment concentration in a single asset class, and expect management to report against those limits routinely.

Longevity concentration across pension transactions deserves the exact same treatment, since the underlying governance logic is identical: a single correlated exposure, however it arose, should not be allowed to grow past a board-approved threshold without an explicit decision to permit it. Boards that already have a mature credit or investment concentration framework do not need to invent a new governance model for this risk, they need to extend the same discipline they already apply elsewhere to a risk that has, until now, been managed only at the transaction level.

Framed this way, adding a longevity concentration limit is not a new governance burden, it is closing a gap in a framework the board already runs for other risks.

Sources

• AM Best: "Reinsurance Appetite For Longevity?"
• LIMRA: "U.S. Single Premium Pension Risk Transfer Product Sales Jump 132% in the Fourth Quarter of 2025"